Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01985087 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70

StatusActive, Not Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 31, 2024 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: 1 to 2v11 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 40 to confirmed 18
    • Secondary endpoints: 3 to 2
    • Site details revised
  2. 2 versions Re-verified since Aug 31, 2020, no change to tracked fieldsv9-v10
  3. Primary completion date: May 2018 to May 2025
    • Study completion date: May 2019 to May 2025
    • Site contact updated
    v8
  4. Lead sponsor: James Graham Brown Cancer Center to University of Louisville
    • Collaborator revised
    v7
  5. 2 versions Re-verified since Feb 29, 2016, no change to tracked fieldsv5-v6
Show 3 earlier versionsHide 3 earlier versions
  1. Study completion date: May 2019v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 2 to 1
    • Start date: Sep 2014
    v3
  3. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Louisville
66 trials monitored
See 2 trials at risk
Glioma
1,251 trials monitored
See 88 trials at risk
Glioblastoma
710 trials monitored
See 52 trials at risk
In this study we propose to determine outcomes of patients age 70 or older treated with radiation over 2 weeks given with temozolomide 75 mg/m2 daily during radiotherapy and as a post radiation treatment of 150 mg/m2 - 200 mg /m2 for 6 cycles or until the disease progresses.
Trial Details
NCT Number NCT01985087
Lead Sponsor University of Louisville
Collaborators: James Graham Brown Cancer Center
Conditions
(from sponsor)		 Glioblastoma
Related terms Glioblastoma
Enrollment 18 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov